Sonoma Pharmaceuticals Inc. - Bathi resik saben saham sajrone patang kuartal pungkasan SNOA

Sonoma Pharmaceuticals (SNOA) is optimizing its supply chains through contract manufacturing and third-party logistics. High margins are achieved via unique patents for molecule stabilization and inelastic demand for wound care treatment. A staff of experienced biochemists supports the business's stability. The annual EPS (TTM) change indicator demonstrates profit dynamics, where the value of 58.80 corresponds to the current metric.
SNOA (Sonoma Pharmaceuticals Inc.): rincian analitis lan laporan miturut indikator

The specifics of Sonoma Pharmaceuticals (SNOA) dermatological pharmaceuticals ensure stable demand regardless of market cycles. This metric reflects the dynamics of net earnings per share over a rolling year, measuring the actual efficiency of capitalization. By analyzing the YoY percentage growth of earnings per share over 12 months on GURU.Markets, an investor sees the current value of 58.80. The positive trajectory confirms the business's resilience to macroeconomic shocks. The asset maintains its status as a defensive instrument with a predictable cash flow.